These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12712228)
1. Cystic fibrosis: bench to bedside 2003. Rubin BK Can Respir J; 2003 Apr; 10(3):161-4. PubMed ID: 12712228 [No Abstract] [Full Text] [Related]
2. Cystic fibrosis and the salt controversy. Guggino WB Cell; 1999 Mar; 96(5):607-10. PubMed ID: 10089875 [No Abstract] [Full Text] [Related]
3. Pulmonary infections in patients with cystic fibrosis. Rajan S; Saiman L Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518 [TBL] [Abstract][Full Text] [Related]
4. Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment. Poschet J; Perkett E; Deretic V Trends Mol Med; 2002 Nov; 8(11):512-9. PubMed ID: 12421684 [TBL] [Abstract][Full Text] [Related]
5. Post-translational modifications of CFTR: insight into protein trafficking and cystic fibrosis disease. Amaral MD; Farinha CM FEBS J; 2013 Sep; 280(18):4395. PubMed ID: 23680006 [No Abstract] [Full Text] [Related]
6. Liquid movement across the surface epithelium of large airways. Chambers LA; Rollins BM; Tarran R Respir Physiol Neurobiol; 2007 Dec; 159(3):256-70. PubMed ID: 17692578 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy for CF. Eubanks M Environ Health Perspect; 2001 Jan; 109(1):A16. PubMed ID: 11171534 [No Abstract] [Full Text] [Related]
9. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. Riordan JR Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337 [No Abstract] [Full Text] [Related]
10. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells. Trinh NT; Bilodeau C; Maillé É; Ruffin M; Quintal MC; Desrosiers MY; Rousseau S; Brochiero E Eur Respir J; 2015 Jun; 45(6):1590-602. PubMed ID: 25792634 [TBL] [Abstract][Full Text] [Related]
11. Developmental paradigm for early features of cystic fibrosis. Larson JE; Cohen JC Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis. Rowe SM; Miller S; Sorscher EJ N Engl J Med; 2005 May; 352(19):1992-2001. PubMed ID: 15888700 [No Abstract] [Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells. LeSimple P; Goepp J; Palmer ML; Fahrenkrug SC; O'Grady SM; Ferraro P; Robert R; Hanrahan JW Am J Respir Cell Mol Biol; 2013 Oct; 49(4):511-6. PubMed ID: 23742042 [TBL] [Abstract][Full Text] [Related]
17. delta F508 in cystic fibrosis: willing but not able. Southern KW Arch Dis Child; 1997 Mar; 76(3):278-82. PubMed ID: 9135274 [No Abstract] [Full Text] [Related]
18. Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein. Schwiebert EM; Benos DJ; Fuller CM Am J Med; 1998 Jun; 104(6):576-90. PubMed ID: 9674722 [No Abstract] [Full Text] [Related]
19. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium. Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935 [TBL] [Abstract][Full Text] [Related]
20. Some immunologic considerations of chronic pulmonary infection in cystic fibrosis. Gifford RR J S C Med Assoc; 1972 May; 68(5):204-7. PubMed ID: 4554120 [No Abstract] [Full Text] [Related] [Next] [New Search]